TY - JOUR
T1 - Sessile serrated adenomas with low- and high-grade dysplasia and early carcinomas
T2 - An immunohistochemical study of serrated lesions "caught in the act"
AU - Sheridan, Todd B.
AU - Fenton, Hubert
AU - Lewin, Marc R.
AU - Burkart, Ashlie L.
AU - Iacobuzio-Donahue, Christine A.
AU - Frankel, Wendy L.
AU - Montgomery, Elizabeth
PY - 2006/10
Y1 - 2006/10
N2 - Sessile serrated adenomas (SSAs) show serrations typical of hyperplastic polyps but display architectural differences and lack traditional dysplasia. SSAs with foci of low- (LGD) or high-grade dysplasia (HGD) or early invasive carcinoma are seldom biopsied and, thus, are not well studied. Immunohistochemical analysis for MLH1, MSH2, MSH6, and PMS2 (mismatch repair gene products) was performed on colon biopsy-specimens from 11 patients (age range, 54-87 years; 4 men and 7 women) showing SSA with LGD (n = 1), HGD (n = 5), or focal invasive carcinoma (n = 5). All 11 cases showed intact nuclear staining for MSH2 and MSH6 in the SSA component; in foci of LGD, HGD, or carcinoma; and in background normal mucosa. In contrast, there was tandem loss of MLH1 and PMS2 in zones of LGD (1/1) or HGD (3/5) and early carcinoma (2/4; with concordant loss in associated HGD) but retention in SSA areas (11/11) and normal mucosa (11/11). No patient was known to have hereditary nonpolyposis colorectal cancer/Lynch syndrome. This study offers additional strong evidence that SSA is truly a precursor to at least a subset of sporadic microsatellite-unstable colorectal cancer.
AB - Sessile serrated adenomas (SSAs) show serrations typical of hyperplastic polyps but display architectural differences and lack traditional dysplasia. SSAs with foci of low- (LGD) or high-grade dysplasia (HGD) or early invasive carcinoma are seldom biopsied and, thus, are not well studied. Immunohistochemical analysis for MLH1, MSH2, MSH6, and PMS2 (mismatch repair gene products) was performed on colon biopsy-specimens from 11 patients (age range, 54-87 years; 4 men and 7 women) showing SSA with LGD (n = 1), HGD (n = 5), or focal invasive carcinoma (n = 5). All 11 cases showed intact nuclear staining for MSH2 and MSH6 in the SSA component; in foci of LGD, HGD, or carcinoma; and in background normal mucosa. In contrast, there was tandem loss of MLH1 and PMS2 in zones of LGD (1/1) or HGD (3/5) and early carcinoma (2/4; with concordant loss in associated HGD) but retention in SSA areas (11/11) and normal mucosa (11/11). No patient was known to have hereditary nonpolyposis colorectal cancer/Lynch syndrome. This study offers additional strong evidence that SSA is truly a precursor to at least a subset of sporadic microsatellite-unstable colorectal cancer.
KW - Carcinoma
KW - Colorectal cancer
KW - Dysplasia
KW - Immunohistochemistry
KW - MLH1
KW - Serrated pathway
KW - Sessile serrated adenoma
UR - http://www.scopus.com/inward/record.url?scp=33749344617&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33749344617&partnerID=8YFLogxK
U2 - 10.1309/C7JE8BVL8420V5VT
DO - 10.1309/C7JE8BVL8420V5VT
M3 - Article
C2 - 16938659
AN - SCOPUS:33749344617
SN - 0002-9173
VL - 126
SP - 564
EP - 571
JO - American journal of clinical pathology
JF - American journal of clinical pathology
IS - 4
ER -